Dolby Laboratories (NYSE:DLB) Releases Quarterly Earnings Results, Misses Expectations By $0.23 EPS

Dolby Laboratories (NYSE:DLBGet Free Report) released its earnings results on Wednesday. The electronics maker reported $0.84 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.23), Zacks reports. Dolby Laboratories had a net margin of 20.56% and a return on equity of 11.19%. Dolby Laboratories updated its FY 2025 guidance to 3.990-4.140 EPS and its Q2 2025 guidance to 1.190-1.340 EPS.

Dolby Laboratories Price Performance

Shares of NYSE:DLB traded down $0.02 during trading on Wednesday, reaching $80.59. 405,447 shares of the company were exchanged, compared to its average volume of 450,844. The firm has a market capitalization of $7.69 billion, a PE ratio of 29.74 and a beta of 0.98. The business’s fifty day simple moving average is $79.18 and its 200-day simple moving average is $75.62. Dolby Laboratories has a 12-month low of $66.35 and a 12-month high of $85.30.

Dolby Laboratories Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 10th. Shareholders of record on Tuesday, December 3rd were paid a $0.33 dividend. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.30. This represents a $1.32 dividend on an annualized basis and a yield of 1.64%. The ex-dividend date of this dividend was Tuesday, December 3rd. Dolby Laboratories’s dividend payout ratio is currently 48.71%.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on DLB shares. Barrington Research restated an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a report on Monday. Rosenblatt Securities reissued a “buy” rating and set a $100.00 price target on shares of Dolby Laboratories in a research note on Thursday, January 23rd. Finally, StockNews.com raised Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, December 4th.

View Our Latest Report on Dolby Laboratories

Insider Buying and Selling

In other Dolby Laboratories news, CAO Ryan Nicholson sold 10,500 shares of the stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $80.18, for a total transaction of $841,890.00. Following the transaction, the chief accounting officer now directly owns 24,364 shares in the company, valued at $1,953,505.52. This represents a 30.12 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Peter C. Gotcher sold 6,079 shares of the stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $78.96, for a total transaction of $479,997.84. Following the transaction, the director now owns 37,593 shares in the company, valued at approximately $2,968,343.28. This represents a 13.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 135,917 shares of company stock valued at $10,877,739 over the last quarter. 38.39% of the stock is owned by corporate insiders.

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

See Also

Earnings History for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.